Press Releases :: BiomX, Inc. (PHGE)

Jan 04, 2022 7:00am EST

BiomX Announces Therapeutics Development Award of up to $5 Million from the Cystic Fibrosis Foundation

Nov 17, 2021 8:00am EST

BiomX Presenting at Two Upcoming Conferences in November

Nov 15, 2021 6:00am EST

BiomX Reports Third Quarter 2021 Financial Results and Provides Business Update

Nov 09, 2021 8:00am EST

BiomX to Host Third Quarter 2021 Financial Results Conference Call and Webcast on November 15, 2021

Oct 18, 2021 7:00am EDT

BiomX Reports Topline Results of Phase 2 Cosmetic Acne Study

Oct 13, 2021 7:00am EDT

BiomX Announces Agreement with Maruho Co., Ltd. for Atopic Dermatitis Product Candidate BX005

Sep 02, 2021 4:05pm EDT

BiomX to Present at Upcoming September Investor Conferences

Aug 16, 2021 6:30am EDT

BiomX Reports Second Quarter 2021 Financial Results and Provides Business Update

Aug 12, 2021 8:00am EDT

BiomX to Host Second Quarter 2021 Financial Results Conference Call and Webcast on August 16, 2021

Jul 26, 2021 8:13am EDT

BiomX Inc. Announces $15 Million Registered Direct Offering

1
2
3
4
5
6
Next

Investor Contact Information

Company

BiomX, Inc.
22 Einstein St.
Floor 5
Ness Ziona 7414003
Israel
info@biomx.com

Investor Relations

Anat Primovich
Corporate Project Manager
T: +972506977228
anatp@biomx.com